Envestnet Asset Management
CALC icon

Envestnet Asset Management’s CalciMedica CALC Stock Holding History

Envestnet Asset Management’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-63,186
Closed -$416K – 4726
2025
Q4 		$416K Sell
63,186
-13,519
-18% -$52.7K ﹤0.01% 3832
2025
Q3 		$236K Sell
76,705
-16,728
-18% -$48.1K ﹤0.01% 4235
2025
Q2 		$149K Buy
93,433
+34,386
+58% +$59K ﹤0.01% 4294
2025
Q1 		$113K Buy
59,047
+12,495
+27% +$31.1K ﹤0.01% 4220
2024
Q4 		$165K Buy
46,552
+2,921
+7% +$10.2K ﹤0.01% 4136
2024
Q3 		$193K Buy
43,631
+21,375
+96% +$94K ﹤0.01% 4024
2024
Q2 		$88.1K Buy
+22,256
New +$112K ﹤0.01% 4065

Other funds holding CALC

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Envestnet Asset Management's CALC Position: Q1 2026 in Review

Envestnet Asset Management sold out of CalciMedica (CALC) in Q1 2026, closing a stake of 63,186 shares — an estimated $416K sold.

Envestnet Asset Management first reported a position in CALC in Q2 2024 and held it in 7 quarters. The position peaked at $416K in Q4 2025. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

  • Envestnet Asset Management reported no remaining CalciMedica position as of Q1 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 63,186 CalciMedica shares in Q1 2026, an estimated $416K.
  • Envestnet Asset Management first reported a position in CalciMedica in Q2 2024 and held it in 7 quarters.
  • Envestnet Asset Management's CalciMedica position peaked at $416K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.